These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10072666)

  • 1. IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.
    Ferber G; Abt K; Fichte K; Luthringer R
    Neuropsychobiology; 1999; 39(2):92-100. PubMed ID: 10072666
    [No Abstract]   [Full Text] [Related]  

  • 2. ITT in respect to GCP: a matter of diligence.
    Van der Weijden F; Slot DE; Rosema M; Timmerman M
    J Clin Periodontol; 2008 Aug; 35(8):681-2. PubMed ID: 18727741
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging standards in statistical practice: implications for clinical trials in rehabilitation medicine.
    Millis SR
    Am J Phys Med Rehabil; 2003 Oct; 82(10 Suppl):S32-7. PubMed ID: 14502037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of overviews of randomized trials.
    Hennekens CH; Buring JE; Hebert PR
    Stat Med; 1987; 6(3):397-409. PubMed ID: 3616292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to ensure your paper is rejected by the statistical reviewer.
    Stratton IM; Neil A
    Diabet Med; 2005 Apr; 22(4):371-3. PubMed ID: 15787658
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials and methodological problems in prion diseases.
    Puopolo M; Pocchiari M; Petrini C
    Lancet Neurol; 2009 Sep; 8(9):782; author reply 782-3. PubMed ID: 19679270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Missing data: warrant for search and capture].
    Torres F; Pontes C
    Med Clin (Barc); 2013 Oct; 141(7):297-9. PubMed ID: 23706686
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the quality of reporting in randomised controlled trials.
    Walker A; Nixon J
    J Wound Care; 2004 Mar; 13(3):103-6. PubMed ID: 15045804
    [No Abstract]   [Full Text] [Related]  

  • 9. The ethics of sample size: two-sided testing and one-sided thinking.
    Knottnerus JA; Bouter LM
    J Clin Epidemiol; 2001 Feb; 54(2):109-10. PubMed ID: 11166523
    [No Abstract]   [Full Text] [Related]  

  • 10. Two-tailed tests and a statistical significance at 0.05: what do they mean?
    Campbell M
    Midwifery; 2004 Jun; 20(2):142-3. PubMed ID: 15177857
    [No Abstract]   [Full Text] [Related]  

  • 11. An introduction to statistical concepts for the analysis of EEG data and the planning of pharmaco-EEG trials.
    Schlattmann P
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():1-6. PubMed ID: 12575482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical practices: the seven deadly sins.
    Millis S
    Child Neuropsychol; 2003 Sep; 9(3):221-33. PubMed ID: 13680411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological advances and plans for improving regulatory success for confirmatory studies.
    Koch GG; Davis SM; Anderson RL
    Stat Med; 1998 Aug 15-30; 17(15-16):1675-90. PubMed ID: 9749439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical significance, power and sample size - what does it all mean?
    Christley RM
    J Small Anim Pract; 2008 Jun; 49(6):263. PubMed ID: 18510495
    [No Abstract]   [Full Text] [Related]  

  • 15. The need for standards, not guidelines, in biological data reporting and sharing.
    Burgoon LD
    Nat Biotechnol; 2006 Nov; 24(11):1369-73. PubMed ID: 17093486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Key factors in design of case report form].
    Fu HJ; Luo XX
    Yao Xue Xue Bao; 2015 Nov; 50(11):1452-5. PubMed ID: 26911041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good study design and analysis plans as features of ethical research with humans.
    Weinberg JM; Kleinman KP
    IRB; 2003; 25(5):11-4. PubMed ID: 14870739
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical considerations in the conduct of clinical pharmacokinetic studies.
    Svensson CK
    Clin Pharmacokinet; 1989 Oct; 17(4):217-22. PubMed ID: 2591138
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative and positive data, statistical power, and confidence intervals.
    Andow DA
    Environ Biosafety Res; 2003; 2(2):75-80. PubMed ID: 15612273
    [No Abstract]   [Full Text] [Related]  

  • 20. Standard operating procedure for the registration and computer-supported evaluation of pharmaco-EEG data. 'EEG in Phase I' of the Collegium Internationale Psychiatriae Scalarum (CIPS).
    Versavel M; Leonard JP; Herrmann WM
    Neuropsychobiology; 1995; 32(3):166-70. PubMed ID: 8544975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.